메뉴 건너뛰기




Volumn 44, Issue 5, 2007, Pages 463-466

The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FIBROBLAST GROWTH FACTOR 23; CALCIUM; CREATININE; FIBROBLAST GROWTH FACTOR; SERUM ALBUMIN;

EID: 38449123062     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307781646102     Document Type: Article
Times cited : (66)

References (17)
  • 2
    • 20244368616 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphataemia
    • Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphataemia. N Engl J Med 2003; 348: 1656-63
    • (2003) N Engl J Med , vol.348 , pp. 1656-1663
    • Jonsson, K.B.1    Zahradnik, R.2    Larsson, T.3
  • 3
    • 14344279878 scopus 로고    scopus 로고
    • Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
    • Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001; 98: 6500-5
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 6500-6505
    • Shimada, T.1    Mizutani, S.2    Muto, T.3
  • 4
    • 0013118819 scopus 로고    scopus 로고
    • The autosomal dominant hypophosphataemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency
    • Bai XY, Miao D, Goltzman D, Karaplis AC. The autosomal dominant hypophosphataemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 2003; 278: 9843-9
    • (2003) J Biol Chem , vol.278 , pp. 9843-9849
    • Bai, X.Y.1    Miao, D.2    Goltzman, D.3    Karaplis, A.C.4
  • 5
    • 15544385175 scopus 로고    scopus 로고
    • Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case
    • Dupond JL, Mahammedi H, Prie D, et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case. Bone 2005; 36: 375-8
    • (2005) Bone , vol.36 , pp. 375-378
    • Dupond, J.L.1    Mahammedi, H.2    Prie, D.3
  • 6
    • 0141453087 scopus 로고    scopus 로고
    • Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia
    • Nelson AE, Bligh RC, Mirams M, et al. Clinical case seminar: fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab 2003; 88: 4088-94
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 4088-4094
    • Nelson, A.E.1    Bligh, R.C.2    Mirams, M.3
  • 7
    • 85047691059 scopus 로고    scopus 로고
    • FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
    • Riminucci M, Collins MT, Fedarko NS, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112: 683-92
    • (2003) J Clin Invest , vol.112 , pp. 683-692
    • Riminucci, M.1    Collins, M.T.2    Fedarko, N.S.3
  • 8
    • 18744371012 scopus 로고    scopus 로고
    • Increased circulatory level of biologically active full length FGF-23 in patients with hypophosphataemic rickets/osteomalacia
    • Yamazaki Y, Okazaki R, Shibata M, et al. Increased circulatory level of biologically active full length FGF-23 in patients with hypophosphataemic rickets/osteomalacia. J Clin Endocrinol Metab 2002; 87: 4957-60
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 4957-4960
    • Yamazaki, Y.1    Okazaki, R.2    Shibata, M.3
  • 9
    • 0035932945 scopus 로고    scopus 로고
    • FGF23, hypophosphataemia, and rickets: Has phosphatonin been found?
    • Strewler GJ. FGF23, hypophosphataemia, and rickets: has phosphatonin been found? Proc Natl Acad Sci USA 2001; 98: 5945-6
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 5945-5946
    • Strewler, G.J.1
  • 10
    • 0035991920 scopus 로고    scopus 로고
    • Is FGF23 the long sought after phosphaturic factor phosphatonin?
    • Silve C, Beck L. Is FGF23 the long sought after phosphaturic factor phosphatonin? Nephrol Dial Transplant 2002; 17: 958-61
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 958-961
    • Silve, C.1    Beck, L.2
  • 11
    • 0038678168 scopus 로고    scopus 로고
    • FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization
    • Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 2003; 285: E1-9
    • (2003) Am J Physiol Endocrinol Metab , vol.285
    • Quarles, L.D.1
  • 12
    • 0347362503 scopus 로고    scopus 로고
    • The phosphatonin pathway: New insights in phosphate homeostasis
    • Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 2004; 65: 1-14
    • (2004) Kidney Int , vol.65 , pp. 1-14
    • Schiavi, S.C.1    Kumar, R.2
  • 13
    • 23944501314 scopus 로고    scopus 로고
    • Role of the vitamin D receptor in FGF23 action on phosphate metabolism
    • Inoue Y, Segawa H, Kaneko I, et al. Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J 2005; 390(Pt 1): 325-31
    • (2005) Biochem J , vol.390 , Issue.PART 1 , pp. 325-331
    • Inoue, Y.1    Segawa, H.2    Kaneko, I.3
  • 14
    • 26844568409 scopus 로고    scopus 로고
    • Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
    • Shimada T, Yamazaki Y, Takahashi M, et al. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 2005; 289: F1088-95
    • (2005) Am J Physiol Renal Physiol , vol.289
    • Shimada, T.1    Yamazaki, Y.2    Takahashi, M.3
  • 15
    • 28444486604 scopus 로고    scopus 로고
    • 1{alpha}, 25-dihydroxy-vitamin D3 up-regulates FGF23 gene expression in bone: The final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport
    • Kolek OI, Hines ER, Jones MD, et al. 1{alpha}, 25-dihydroxy-vitamin D3 up-regulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005; 289: 1036-42
    • (2005) Am J Physiol Gastrointest Liver Physiol , vol.289 , pp. 1036-1042
    • Kolek, O.I.1    Hines, E.R.2    Jones, M.D.3
  • 16
    • 29144500469 scopus 로고    scopus 로고
    • Structural and biochemical properties of fibroblast growth factor 23
    • Yamashita T. Structural and biochemical properties of fibroblast growth factor 23. Ther Apher Dial 2005; 9: 313-18
    • (2005) Ther Apher Dial , vol.9 , pp. 313-318
    • Yamashita, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.